Skip to main content

AHRQ Archives

Interventions benefit disruptive behavior in children: review

Oct. 29, 2015—Children with disruptive behavior disorders (DBDs), such as conduct disorder, are most likely to benefit from psychosocial interventions that include a parental component alone or in combination with other interventions, according to a newly published systematic review by Vanderbilt researchers.

Read more


Grant spurs lung cancer surgery research

Sep. 18, 2014—Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.

Read more


Behavior-focused therapies help children with autism: study

Jul. 26, 2014—Vanderbilt researchers this week reported updated findings regarding the benefits of behavior-focused therapies for children with autism spectrum disorder (ASD).

Read more


VU study shows common diabetes drug can slow chronic kidney disease progression

Jun. 26, 2014—Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes.

Read more


Grant bolsters patient-centered outcomes research

Mar. 27, 2014—Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ).

Read more


Little evidence supports medical treatment options for adolescents with autism

Sep. 24, 2012—Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.

Read more


Study tracks hormone’s role in reducing preterm birth risk

Sep. 6, 2012—Pregnant women who have had prior preterm births may avoid a subsequent early birth if given progestogens, which are natural or synthetic forms of progesterone, a female hormone that naturally increases during pregnancy, a Vanderbilt analysis shows.

Read more


Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more